Satoshi Setoguchi
Direktor/Vorstandsmitglied bei ASTENA HOLDINGS CO., LTD.
Vermögen: 216 919 $ am 30.04.2024
Profil
Satoshi Setoguchi is currently working as the President, CEO, Chief Operating Officer & Director at Iwaki & Co., Ltd.
He is also serving as the Director & Managing Executive Officer at Astena Holdings Co., Ltd.
since 2020 and as a Director at Apros Corp.
since 2015.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ASTENA HOLDINGS CO.,LTD.
0,17% | 30.11.2023 | 69 100 ( 0,17% ) | 216 919 $ | 30.04.2024 |
Aktive Positionen von Satoshi Setoguchi
| Unternehmen | Position | Beginn |
|---|---|---|
| ASTENA HOLDINGS CO., LTD. | Direktor/Vorstandsmitglied | 01.02.2019 |
| Apros Corp. | Direktor/Vorstandsmitglied | 01.12.2015 |
Iwaki & Co., Ltd.
 Iwaki & Co., Ltd. Drugstore ChainsRetail Trade Part of Astena Holdings Co., Ltd., Iwaki & Co., Ltd. is a bio development group that offers a wide range of services including drug discovery screening kits, ELISA kits, antibody reagents, antibody-produced services, and drugs for in vitro diagnosis and related products. Iwaki & Co. is based in Tokyo, JP. The Japanese company also provides planning, development, and sales support for commercialization of researchers' latest technology from overseas/domestic venture companies. The company was founded in 2020, and the CEO is Satoshi Setoguchi. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ASTENA HOLDINGS CO., LTD. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Apros Corp. | |
Iwaki & Co., Ltd.
Iwaki & Co., Ltd. Drugstore ChainsRetail Trade Part of Astena Holdings Co., Ltd., Iwaki & Co., Ltd. is a bio development group that offers a wide range of services including drug discovery screening kits, ELISA kits, antibody reagents, antibody-produced services, and drugs for in vitro diagnosis and related products. Iwaki & Co. is based in Tokyo, JP. The Japanese company also provides planning, development, and sales support for commercialization of researchers' latest technology from overseas/domestic venture companies. The company was founded in 2020, and the CEO is Satoshi Setoguchi. | Retail Trade |
